Related Experiment Video
Updated: Jan 21, 2026

Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
Published on: April 25, 2025
DNA vaccine encoding OmpA and Pal from Acinetobacter baumannii efficiently protects mice against pulmonary infection
Langhuan Lei1,2,3,4, Feng Yang5, Jintao Zou5
1Department of Critical Care Medicine, Children's Hospital of Chongqing Medical University, Chongqing, 400014, China.
Abstract:
Acinetobacter baumannii (A. baumannii) is an opportunistic pathogen that causes serious infections in the lungs, blood, and brain in critically ill hospital patients, resulting in considerable mortality rates every year. Due to the rapid appearance of multi-drug resistance or even pan-drug resistance isolates, it is becoming more and more difficult to cure A. baumannii infection by traditional antibiotic treatment, alternative strategies are urgently required to combat A. baumannii infection. In this study, we developed a DNA vaccine encoding two antigens from A. baumannii, OmpA and Pal, and the immunogenicity and protective efficacy was further evaluated. The results showed that the DNA vaccine exhibited significant immune protective efficacy against acute A. baumannii infection in a mouse pneumonia model, and cross protective efficacy was observed when immunized mice were challenged with clinical strains of A. baumannii. DNA vaccine immunization induced high level of humoral response and a mixed Th1/Th2/Th17 cellular response, which protect against lethal bacterial challenges by decreased bacterial loads and pathology in the lungs, and reduced level of inflammatory cytokines expression and inflammatory cell infiltration in BALF. These results demonstrated that it is possible to prevent A. baumannii infection by DNA vaccine and both OmpA and Pal could be serve as promising candidate antigens.
Insights
A new DNA vaccine targeting Acinetobacter baumannii (A. baumannii) shows promise in preventing infections. This vaccine, using OmpA and Pal antigens, effectively protected mice against lethal bacterial challenges and reduced lung damage.
Area of Science:
- Microbiology
- Immunology
- Vaccine Development
Background:
- Acinetobacter baumannii (A. baumannii) is a critical opportunistic pathogen causing severe hospital-acquired infections.
- Multi-drug and pan-drug resistance in A. baumannii necessitates novel therapeutic and preventative strategies.
- Traditional antibiotic treatments are increasingly ineffective against resistant A. baumannii strains.
Purpose of the Study:
- To develop and evaluate a DNA vaccine encoding A. baumannii OmpA and Pal antigens.
- To assess the immunogenicity and protective efficacy of the developed DNA vaccine.
- To investigate the immune responses induced by the DNA vaccine against A. baumannii.
Main Methods:
- Development of a DNA vaccine encoding two A. baumannii antigens: OmpA and Pal.
- Evaluation of vaccine immunogenicity and protective efficacy in a mouse pneumonia model.
- Assessment of humoral and cellular immune responses (Th1/Th2/Th17), bacterial loads, lung pathology, and inflammatory markers.
Main Results:
- The DNA vaccine demonstrated significant immune protective efficacy against acute A. baumannii infection.
- Cross-protective efficacy was observed against clinical strains of A. baumannii.
- Vaccine immunization induced high humoral and mixed Th1/Th2/Th17 cellular responses, reducing bacterial load, lung pathology, and inflammation.
Conclusions:
- A DNA vaccine encoding OmpA and Pal antigens is a viable strategy for preventing A. baumannii infections.
- OmpA and Pal are promising candidate antigens for developing effective vaccines against A. baumannii.
- The DNA vaccine offers a potential alternative to antibiotics for combating challenging A. baumannii infections.
Related Concept Videos
Vaccinations
Encoding
Automatic processing involves the encoding of details like time, space, frequency, and the meaning of words, usually done without conscious...
DNA-only Transposons
The donor site from where the transposon is excised is either degraded or...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Zones of Protection
Protective zones are defined by closed dashed lines, containing one or more components. A key characteristic of these zones is the strategic placement of...
Protection of Alcohols
Protection
It defines a protecting group as the masking agent to make the more reactive species inert to a given set of conditions. This concept is depicted via the illustration of liquid flow through different outlets in an assembly of pipes. The analogy helps to understand the role...

